The global Heavy Ion Radiotherapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Heavy Ion Radiotherapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Heavy Ion Radiotherapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Heavy Ion Radiotherapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Heavy Ion Radiotherapy players cover Toshiba Energy, Sumitomo Heavy Industries, Ltd., Hitachi, Nature, IOPscience, Bayer, Mitsubishi Electric, Varian Medical Systems and Accuray, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Heavy Ion Radiotherapy is a method of treating tumors with heavy ion radiation accelerated to 70% of the speed of light.
LPI (LP Information)' newest research report, the “Heavy Ion Radiotherapy Industry Forecast” looks at past sales and reviews total world Heavy Ion Radiotherapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Heavy Ion Radiotherapy sales for 2023 through 2029. With Heavy Ion Radiotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Heavy Ion Radiotherapy industry.
This Insight Report provides a comprehensive analysis of the global Heavy Ion Radiotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Heavy Ion Radiotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Heavy Ion Radiotherapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Heavy Ion Radiotherapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Heavy Ion Radiotherapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Heavy Ion Radiotherapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Internal Radiotherapy
External Radiotherapy
Segmentation by application
Hospitals
Ambulatory Radiotherapy Centers
Cancer Research Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Toshiba Energy
Sumitomo Heavy Industries, Ltd.
Hitachi
Nature
IOPscience
Bayer
Mitsubishi Electric
Varian Medical Systems
Accuray
Elekta
Mevion Medical Systems
Panacea Medical Technologies
Provision Healthcare
ViewRay
IsoRay Medical

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Heavy Ion Radiotherapy Market Size 2018-2029 2.1.2 Heavy Ion Radiotherapy Market Size CAGR by Region 2018 VS 2022 VS 2029 2.2 Heavy Ion Radiotherapy Segment by Type 2.2.1 Internal Radiotherapy 2.2.2 External Radiotherapy 2.3 Heavy Ion Radiotherapy Market Size by Type 2.3.1 Heavy Ion Radiotherapy Market Size CAGR by Type (2018 VS 2022 VS 2029) 2.3.2 Global Heavy Ion Radiotherapy Market Size Market Share by Type (2018-2023) 2.4 Heavy Ion Radiotherapy Segment by Application 2.4.1 Hospitals 2.4.2 Ambulatory Radiotherapy Centers 2.4.3 Cancer Research Institutes 2.4.4 Others 2.5 Heavy Ion Radiotherapy Market Size by Application 2.5.1 Heavy Ion Radiotherapy Market Size CAGR by Application (2018 VS 2022 VS 2029) 2.5.2 Global Heavy Ion Radiotherapy Market Size Market Share by Application (2018-2023) 3 Heavy Ion Radiotherapy Market Size by Player 3.1 Heavy Ion Radiotherapy Market Size Market Share by Players 3.1.1 Global Heavy Ion Radiotherapy Revenue by Players (2018-2023) 3.1.2 Global Heavy Ion Radiotherapy Revenue Market Share by Players (2018-2023) 3.2 Global Heavy Ion Radiotherapy Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Heavy Ion Radiotherapy by Regions 4.1 Heavy Ion Radiotherapy Market Size by Regions (2018-2023) 4.2 Americas Heavy Ion Radiotherapy Market Size Growth (2018-2023) 4.3 APAC Heavy Ion Radiotherapy Market Size Growth (2018-2023) 4.4 Europe Heavy Ion Radiotherapy Market Size Growth (2018-2023) 4.5 Middle East & Africa Heavy Ion Radiotherapy Market Size Growth (2018-2023) 5 Americas 5.1 Americas Heavy Ion Radiotherapy Market Size by Country (2018-2023) 5.2 Americas Heavy Ion Radiotherapy Market Size by Type (2018-2023) 5.3 Americas Heavy Ion Radiotherapy Market Size by Application (2018-2023) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Heavy Ion Radiotherapy Market Size by Region (2018-2023) 6.2 APAC Heavy Ion Radiotherapy Market Size by Type (2018-2023) 6.3 APAC Heavy Ion Radiotherapy Market Size by Application (2018-2023) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Heavy Ion Radiotherapy by Country (2018-2023) 7.2 Europe Heavy Ion Radiotherapy Market Size by Type (2018-2023) 7.3 Europe Heavy Ion Radiotherapy Market Size by Application (2018-2023) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Heavy Ion Radiotherapy by Region (2018-2023) 8.2 Middle East & Africa Heavy Ion Radiotherapy Market Size by Type (2018-2023) 8.3 Middle East & Africa Heavy Ion Radiotherapy Market Size by Application (2018-2023) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Heavy Ion Radiotherapy Market Forecast 10.1 Global Heavy Ion Radiotherapy Forecast by Regions (2024-2029) 10.1.1 Global Heavy Ion Radiotherapy Forecast by Regions (2024-2029) 10.1.2 Americas Heavy Ion Radiotherapy Forecast 10.1.3 APAC Heavy Ion Radiotherapy Forecast 10.1.4 Europe Heavy Ion Radiotherapy Forecast 10.1.5 Middle East & Africa Heavy Ion Radiotherapy Forecast 10.2 Americas Heavy Ion Radiotherapy Forecast by Country (2024-2029) 10.2.1 United States Heavy Ion Radiotherapy Market Forecast 10.2.2 Canada Heavy Ion Radiotherapy Market Forecast 10.2.3 Mexico Heavy Ion Radiotherapy Market Forecast 10.2.4 Brazil Heavy Ion Radiotherapy Market Forecast 10.3 APAC Heavy Ion Radiotherapy Forecast by Region (2024-2029) 10.3.1 China Heavy Ion Radiotherapy Market Forecast 10.3.2 Japan Heavy Ion Radiotherapy Market Forecast 10.3.3 Korea Heavy Ion Radiotherapy Market Forecast 10.3.4 Southeast Asia Heavy Ion Radiotherapy Market Forecast 10.3.5 India Heavy Ion Radiotherapy Market Forecast 10.3.6 Australia Heavy Ion Radiotherapy Market Forecast 10.4 Europe Heavy Ion Radiotherapy Forecast by Country (2024-2029) 10.4.1 Germany Heavy Ion Radiotherapy Market Forecast 10.4.2 France Heavy Ion Radiotherapy Market Forecast 10.4.3 UK Heavy Ion Radiotherapy Market Forecast 10.4.4 Italy Heavy Ion Radiotherapy Market Forecast 10.4.5 Russia Heavy Ion Radiotherapy Market Forecast 10.5 Middle East & Africa Heavy Ion Radiotherapy Forecast by Region (2024-2029) 10.5.1 Egypt Heavy Ion Radiotherapy Market Forecast 10.5.2 South Africa Heavy Ion Radiotherapy Market Forecast 10.5.3 Israel Heavy Ion Radiotherapy Market Forecast 10.5.4 Turkey Heavy Ion Radiotherapy Market Forecast 10.5.5 GCC Countries Heavy Ion Radiotherapy Market Forecast 10.6 Global Heavy Ion Radiotherapy Forecast by Type (2024-2029) 10.7 Global Heavy Ion Radiotherapy Forecast by Application (2024-2029) 11 Key Players Analysis 11.1 Toshiba Energy 11.1.1 Toshiba Energy Company Information 11.1.2 Toshiba Energy Heavy Ion Radiotherapy Product Offered 11.1.3 Toshiba Energy Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023) 11.1.4 Toshiba Energy Main Business Overview 11.1.5 Toshiba Energy Latest Developments 11.2 Sumitomo Heavy Industries, Ltd. 11.2.1 Sumitomo Heavy Industries, Ltd. Company Information 11.2.2 Sumitomo Heavy Industries, Ltd. Heavy Ion Radiotherapy Product Offered 11.2.3 Sumitomo Heavy Industries, Ltd. Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023) 11.2.4 Sumitomo Heavy Industries, Ltd. Main Business Overview 11.2.5 Sumitomo Heavy Industries, Ltd. Latest Developments 11.3 Hitachi 11.3.1 Hitachi Company Information 11.3.2 Hitachi Heavy Ion Radiotherapy Product Offered 11.3.3 Hitachi Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023) 11.3.4 Hitachi Main Business Overview 11.3.5 Hitachi Latest Developments 11.4 Nature 11.4.1 Nature Company Information 11.4.2 Nature Heavy Ion Radiotherapy Product Offered 11.4.3 Nature Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023) 11.4.4 Nature Main Business Overview 11.4.5 Nature Latest Developments 11.5 IOPscience 11.5.1 IOPscience Company Information 11.5.2 IOPscience Heavy Ion Radiotherapy Product Offered 11.5.3 IOPscience Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023) 11.5.4 IOPscience Main Business Overview 11.5.5 IOPscience Latest Developments 11.6 Bayer 11.6.1 Bayer Company Information 11.6.2 Bayer Heavy Ion Radiotherapy Product Offered 11.6.3 Bayer Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023) 11.6.4 Bayer Main Business Overview 11.6.5 Bayer Latest Developments 11.7 Mitsubishi Electric 11.7.1 Mitsubishi Electric Company Information 11.7.2 Mitsubishi Electric Heavy Ion Radiotherapy Product Offered 11.7.3 Mitsubishi Electric Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023) 11.7.4 Mitsubishi Electric Main Business Overview 11.7.5 Mitsubishi Electric Latest Developments 11.8 Varian Medical Systems 11.8.1 Varian Medical Systems Company Information 11.8.2 Varian Medical Systems Heavy Ion Radiotherapy Product Offered 11.8.3 Varian Medical Systems Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023) 11.8.4 Varian Medical Systems Main Business Overview 11.8.5 Varian Medical Systems Latest Developments 11.9 Accuray 11.9.1 Accuray Company Information 11.9.2 Accuray Heavy Ion Radiotherapy Product Offered 11.9.3 Accuray Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023) 11.9.4 Accuray Main Business Overview 11.9.5 Accuray Latest Developments 11.10 Elekta 11.10.1 Elekta Company Information 11.10.2 Elekta Heavy Ion Radiotherapy Product Offered 11.10.3 Elekta Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023) 11.10.4 Elekta Main Business Overview 11.10.5 Elekta Latest Developments 11.11 Mevion Medical Systems 11.11.1 Mevion Medical Systems Company Information 11.11.2 Mevion Medical Systems Heavy Ion Radiotherapy Product Offered 11.11.3 Mevion Medical Systems Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023) 11.11.4 Mevion Medical Systems Main Business Overview 11.11.5 Mevion Medical Systems Latest Developments 11.12 Panacea Medical Technologies 11.12.1 Panacea Medical Technologies Company Information 11.12.2 Panacea Medical Technologies Heavy Ion Radiotherapy Product Offered 11.12.3 Panacea Medical Technologies Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023) 11.12.4 Panacea Medical Technologies Main Business Overview 11.12.5 Panacea Medical Technologies Latest Developments 11.13 Provision Healthcare 11.13.1 Provision Healthcare Company Information 11.13.2 Provision Healthcare Heavy Ion Radiotherapy Product Offered 11.13.3 Provision Healthcare Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023) 11.13.4 Provision Healthcare Main Business Overview 11.13.5 Provision Healthcare Latest Developments 11.14 ViewRay 11.14.1 ViewRay Company Information 11.14.2 ViewRay Heavy Ion Radiotherapy Product Offered 11.14.3 ViewRay Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023) 11.14.4 ViewRay Main Business Overview 11.14.5 ViewRay Latest Developments 11.15 IsoRay Medical 11.15.1 IsoRay Medical Company Information 11.15.2 IsoRay Medical Heavy Ion Radiotherapy Product Offered 11.15.3 IsoRay Medical Heavy Ion Radiotherapy Revenue, Gross Margin and Market Share (2018-2023) 11.15.4 IsoRay Medical Main Business Overview 11.15.5 IsoRay Medical Latest Developments 12 Research Findings and Conclusion